Table 1.
Demographic and Clinical Characteristics of HL in Survivor Cohort
| Characteristic | Patients |
|
|---|---|---|
| No. (N = 253) | % | |
| Year of HL diagnosis | ||
| Before 1980 | 136 | 54 |
| 1980-1989 | 97 | 38 |
| ≥ 1990 | 20 | 8 |
| HL stage at diagnosis | ||
| I | 38 | 15 |
| II | 155 | 61 |
| III | 27 | 11 |
| IV | 13 | 5 |
| Unknown | 20 | 8 |
| “B” symptoms at diagnosis | ||
| No | 158 | 62 |
| Yes | 63 | 25 |
| Unknown | 32 | 13 |
| Lymph node involvement | ||
| Mediastinal hilar | 164 | 65 |
| Supraclavicular/infraclavicular | 134 | 53 |
| Cervical | 126 | 50 |
| Axillary | 38 | 15 |
| Abdominal | 14 | 6 |
| Pelvic | 3 | 1 |
| Other | 34 | 13 |
| Chemotherapy | ||
| No | 156 | 62 |
| Yes | 88 | 35 |
| Unknown | 9 | 4 |
| Radiation dose, Gy | ||
| Median | 39 | |
| Range | 10-50 | |
| Age at HL diagnosis, years | ||
| Median | 23 | |
| Range | 11-67 | |
| Age at BC diagnosis, years | ||
| Median | 42 | |
| Range | 24-84 | |
| Interval from HL to BC, years | ||
| Median | 18 | |
| Range | 1-42 | |
Abbreviations: HL, Hodgkin's lymphoma; BC, breast cancer.